Under construction – not a live service
Sign in
Taking people in GermanyNo phase

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Key facts

Where
Cologne and Düsseldorf, GermanySee the 2 sites

Where in Germany

  • Universitätsklinikum Köln, Klinik III für Innere Medizin, Herzzentrum, Kerpener Straße 62Cologne, GermanyContact: Matti Adam, PD Dr.Taking people
  • Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & AngiologieDüsseldorf, GermanyContact: Christian Jung, Prof. MD PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Heinrich-Heine University, Duesseldorf
Trial code
NCT05552352
Record updated
28 August 2025
Original description
This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.Read full original descriptionShow less

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

Inclusion: High-grade aortic valve stenosis; Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI); Existing heart center decision; Age ≥ 18 years; Signed informed consent form.

Exclusion: Surgery planned under general anesthesia; Severe hearing impairment, preventing the patient from understanding the sound of the VR goggles, tested with the VR goggles fitted without using the VRAP-Heart software; Severe visual impairment that prevents viewing of the VR modules if it is not possible to use existing visual corrections (contact lenses, glasses) together with the VR glasses in the event of defective vision, tested with the VR goggles fitted without using the VRAP-Heart software; Moderately severe or severe dementia syndrome noted in the medical history or identified during the informed consent discussion; Known seizure disorder (epilepsy); Any psychosocial condition that makes compliance with the protocol unlikely; Language barrier, defined as insufficient language proficiency at the discretion of the investigator to understand the purpose of the trial and follow the VR application; Positive pregnancy test on inclusion and/or pregnancy is present; Court ordered placement in an institution.

ClinicalTrials.gov NCT05552352